Seres Therapeutics to Initiate New SER-109 Clinical Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI
6. ROST
7. BILL
8. MRK
9. MRNA
10. NTES

Go back to Seres Therapeutics to Initiate New SER-109 Clinical Study
(NASDAQ: MCRB) Delayed: 4.57 -0.11 (2.35%)
Previous Close $4.68    52 Week High $44.51 
Open $4.64    52 Week Low $8.05 
Day High $4.69    P/E N/A 
Day Low $4.39    EPS $0.00 
Volume 74,039